CompletedNot Applicable

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

United States69 participantsStarted 2023-09-22

Plain-language summary

This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients will need to have decompensated cirrhosis defined as a Child Pugh Score ≥ 7 Exclusion Criteria: * None

What they're measuring

Change in Mean Arterial Pressure

Timeframe: Baseline and 24 Weeks

Trial details

NCT IDNCT05928624

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-01

Results submitted2025-07-02

View on ClinicalTrials.gov More Cirrhosis, Liver trials